As markets react wildly to the coronavirus pandemic, investors are relying on nowcasting tools like surveys and web-scraping to determine the true size of the macroeconomic fallout.
Top machine learning researcher Marcos López de Prado is highlighting the power of machine learning techniques for financial data analysis, noting that — contrary to popular belief — ML techniques offer a better guard against overfitting than classical econometrics.
To aid our clients in navigating the unprecedented situation that the global economy now faces, we have collated a list of 40 free alternative data sources, over 90% of which are updated at weekly-or-higher frequencies. Highlights include human temperature mapping from smart thermometers, country-level internet pressure tracking, and global foot traffic data sourced from 128 countries.
European courts are restricting ESG ratings agencies from doling out negative sustainability scores when they can’t find enough data to prove how a company is approaching its ESG practices.
On Thursday, Neudata’s Daryl Smith, Amy Dafnis and Helena Yu delivered a presentation to the industry on the alternative datasets most well-positioned to forecast China’s recovery efforts, highlight the potential implications for the global healthcare, tourism and travel sectors, and model the disease’s future spread.
PanAgora Asset Management has continued to see strong performance of its quantitative portfolio focused on environmental, social and governance (ESG) factors three years after the strategy was launched.
As the number of confirmed cases of COVID-19 continues to grow, asset managers are seeking out granular healthcare datasets to track the true spread of the disease ahead of officially reported statistics.
Neudata presented to clients on the alternative datasets most well-positioned to forecast China’s recovery efforts, highlight the potential implications for the global healthcare, tourism and travel sectors, as well as to model the disease’s future spread.
Where to begin? As of March 11th, the world has been officially diagnosed with a pandemic and is now standing on the brink of a global recession. Here follows Neudata’s attempt to guide our clients through the most pertain alternative data products: from China’s recovery, to macro-level economic insights, supply chain analysis, healthcare and tourism sectors, and, finally, epidemiological data on the virus itself.
As the fallout related to COVID-19 continues to ripple through financial markets, European regulators are taking a strong position against short sellers.
Find out more about Neudata and keep up-to-date by signing up to our email newsletter.
